More News

20 Sep 2023 Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines
20 Sep 2023 Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
19 Sep 2023 Pharmanovia acquires global central nervous system (CNS) portfolio from Sanofi
12 Sep 2023 Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer
12 Sep 2023 Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform
11 Sep 2023 Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium
09 Sep 2023 Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
05 Sep 2023 XtalPi and Parthenon Enter Into AI-Powered Antibody Discovery Partnership
01 Sep 2023 Otsuka Pharmaceutical to Acquire Mindset Pharma
01 Sep 2023 Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases.
31 Aug 2023 Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
29 Aug 2023 Verastem Oncology Enters Discovery and Development Collaboration with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers
29 Aug 2023 Deargen and Serengen Partner to Accelerate Drug Discovery
23 Aug 2023 Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
22 Aug 2023 LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals
16 Aug 2023 Chiesi Global Rare Diseases Announces Co-Development Agreement with Aliada Therapeutics to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
16 Aug 2023 Gilead and Tentarix to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation
15 Aug 2023 Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.
12 Aug 2023 HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK Cells
11 Aug 2023 Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
11 Aug 2023 Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
28 Jul 2023 Biogen to Acquire Reata Pharmaceuticals
27 Jul 2023 Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
26 Jul 2023 AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets
26 Jul 2023 Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up